Avid Bioservices (CDMO) News Today $12.14 +0.21 (+1.76%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Punch and Associates sends letter to Board of Directors of Avid Bioservices, Inc.November 14 at 5:38 PM | businesswire.comAvid Bioservices, Inc. (NASDAQ:CDMO) Shares Acquired by GSA Capital Partners LLPGSA Capital Partners LLP increased its holdings in Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 97.3% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 153,070 shares of the biopharmaceutical company's stock after buying an additional 75,473 shares duNovember 13, 2024 | marketbeat.comAvid Bioservices (NASDAQ:CDMO) Sees Large Volume Increase - Should You Buy?November 10, 2024 | americanbankingnews.comAVID BIOSERVICES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avid Bioservices, Inc. - CDMONovember 9, 2024 | businesswire.comTustin-based Biotech Company Avid Bioservices Inc. To Go Private in $850M DealNovember 9, 2024 | latimes.comAvid Bioservices: Take-Private Deal At A Reasonable Price, Maintaining BuyNovember 9, 2024 | seekingalpha.comAvid Bioservices (NASDAQ:CDMO) Sees Strong Trading Volume - What's Next?Avid Bioservices (NASDAQ:CDMO) Sees Unusually-High Trading Volume - What's Next?November 8, 2024 | marketbeat.comRBC Capital Downgrades Avid Bioservices (CDMO)November 8, 2024 | msn.comSHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Avid Bioservices, Inc. – CDMONovember 8, 2024 | globenewswire.comAvid Bioservices to be Acquired in $1.1 Billion DealNovember 8, 2024 | markets.businessinsider.comShareholder Alert: Ademi LLP Investigates Whether Avid Bioservices, Inc. Is Obtaining a Fair Price for Its Public ShareholdersNovember 8, 2024 | businesswire.comGHO and Ampersand Capital to acquire Avid BioservicesNovember 7, 2024 | msn.comAvid Bioservices to be acquired for $1.1B in cash by GHO, AmpersandNovember 7, 2024 | msn.comCraig-Hallum Sticks to Its Buy Rating for Avid Bioservices (CDMO)November 7, 2024 | markets.businessinsider.comCDMO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Avid Bioservices, Inc. Is Fair to ShareholdersNovember 7, 2024 | businesswire.comALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Avid Bioservices, Inc.November 7, 2024 | prnewswire.comAvid Bioservices (NASDAQ:CDMO) Shares Gap Up - What's Next?Avid Bioservices (NASDAQ:CDMO) Shares Gap Up - Should You Buy?November 7, 2024 | marketbeat.comCDMO Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Avid Bioservices to GHO Capital Partners and Ampersand Capital PartnersNovember 7, 2024 | globenewswire.comWilliam Blair Reiterates Market Perform Rating for Avid Bioservices (NASDAQ:CDMO)William Blair reaffirmed a "market perform" rating on shares of Avid Bioservices in a research report on Thursday.November 7, 2024 | marketbeat.comAvid Bioservices (NASDAQ:CDMO) Receives "Sector Perform" Rating from Royal Bank of CanadaRoyal Bank of Canada restated a "sector perform" rating and issued a $12.50 target price (up from $12.00) on shares of Avid Bioservices in a research note on Thursday.November 7, 2024 | marketbeat.comAvid Bioservices to be taken private by GHO, Ampersand in $1.1 billion dealNovember 6, 2024 | msn.comAvid Bioservices to Go Private in $1.1 Billion DealNovember 6, 2024 | msn.comAvid Bioservices to be acquired by GHO and Ampersand for about $1.1 blnNovember 6, 2024 | reuters.comAvid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion TransactionNovember 6, 2024 | globenewswire.com1,448,916 Shares in Avid Bioservices, Inc. (NASDAQ:CDMO) Acquired by Emerald Advisers LLCEmerald Advisers LLC purchased a new position in shares of Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 1,448,916 shares of the biopharmaceutical coNovember 3, 2024 | marketbeat.comAvid Bioservices, Inc. (NASDAQ:CDMO) Receives Consensus Rating of "Moderate Buy" from BrokeragesShares of Avid Bioservices, Inc. (NASDAQ:CDMO - Get Free Report) have received an average rating of "Moderate Buy" from the five ratings firms that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and four have assigned a buyOctober 30, 2024 | marketbeat.comInsider Selling: Avid Bioservices, Inc. (NASDAQ:CDMO) Insider Sells 2,031 Shares of StockOctober 12, 2024 | insidertrades.comAvid Bioservices, Inc. (NASDAQ:CDMO) Shares Acquired by Cubist Systematic Strategies LLCCubist Systematic Strategies LLC grew its holdings in Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 112.5% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 341,311 shares of the biopharmaceutical company's stock after purchasing anOctober 12, 2024 | marketbeat.comRichard A. Richieri Sells 2,031 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO) StockAvid Bioservices, Inc. (NASDAQ:CDMO - Get Free Report) insider Richard A. Richieri sold 2,031 shares of the business's stock in a transaction that occurred on Thursday, October 10th. The shares were sold at an average price of $10.05, for a total value of $20,411.55. Following the completion of the sale, the insider now directly owns 37,704 shares of the company's stock, valued at approximately $378,925.20. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link.October 11, 2024 | marketbeat.comSquarepoint Ops LLC Sells 341,119 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO)Squarepoint Ops LLC trimmed its stake in shares of Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 87.0% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 50,933 shares of the biopharmaceutical company's stock after selliOctober 11, 2024 | marketbeat.comMarshall Wace LLP Acquires New Holdings in Avid Bioservices, Inc. (NASDAQ:CDMO)Marshall Wace LLP acquired a new stake in shares of Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 195,461 shares of the biophOctober 7, 2024 | marketbeat.comAvid Bioservices (NASDAQ:CDMO) Stock Quotes, Forecast and News SummaryOctober 4, 2024 | benzinga.comMillennium Management LLC Acquires 695,512 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO)Millennium Management LLC increased its stake in Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 15.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,099,529 shares of the biopharmaceutical company'sOctober 3, 2024 | marketbeat.comPoint72 Asset Management L.P. Buys 904,733 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO)Point72 Asset Management L.P. grew its stake in shares of Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 51.2% in the second quarter, according to the company in its most recent filing with the SEC. The firm owned 2,673,050 shares of the biopharmaceutical company's stock after acquiring an aSeptember 30, 2024 | marketbeat.comAvid Bioservices, Inc. (NASDAQ:CDMO) Shares Sold by Profund Advisors LLCProfund Advisors LLC reduced its position in shares of Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 58.1% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 33,965 shares of the biopharmaceutical company's stock aftSeptember 29, 2024 | marketbeat.comAvid Bioservices, Inc. (NASDAQ:CDMO) Shares Bought by Deerfield Management Company L.P. Series CDeerfield Management Company L.P. Series C raised its position in Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 73.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 176,586 shares of the biopharmSeptember 26, 2024 | marketbeat.comAvid Bioservices, Inc. (NASDAQ:CDMO) Shares Sold by AYAL Capital Advisors LtdAYAL Capital Advisors Ltd lowered its stake in shares of Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 26.8% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 768,662 shares of the biopharmaceutSeptember 25, 2024 | marketbeat.comAvid Bioservices, Inc. (NASDAQ:CDMO) Shares Sold by 272 Capital LP272 Capital LP trimmed its position in shares of Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 67.3% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 264,540 shares of the biopharmaceutical company's stock after selling 545,453 sharSeptember 24, 2024 | marketbeat.comAvid Bioservices (NASDAQ:CDMO) Shares Up 6.3%Avid Bioservices (NASDAQ:CDMO) Trading Up 6.3%September 19, 2024 | marketbeat.comAltraVue Capital LLC Buys 239,343 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO)AltraVue Capital LLC lifted its stake in Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 7.6% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,395,263 shares of the biopharmaceutical company's stock after buying anSeptember 19, 2024 | marketbeat.comAvid Bioservices (NASDAQ:CDMO) Trading Down 2.5%Avid Bioservices (NASDAQ:CDMO) Trading Down 2.5%September 18, 2024 | marketbeat.comAvid Bioservices (NASDAQ:CDMO) Sets New 1-Year High at $11.71Avid Bioservices (NASDAQ:CDMO) Hits New 52-Week High at $11.71September 17, 2024 | marketbeat.comSargent Investment Group LLC Sells 94,475 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO)Sargent Investment Group LLC cut its holdings in Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 13.7% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 595,980 shares of the biopharmaceutical company's stock after selling 94,4September 17, 2024 | marketbeat.comQ2 2025 EPS Estimates for Avid Bioservices, Inc. (NASDAQ:CDMO) Cut by William BlairAvid Bioservices, Inc. (NASDAQ:CDMO - Free Report) - Investment analysts at William Blair dropped their Q2 2025 earnings per share (EPS) estimates for Avid Bioservices in a research note issued to investors on Tuesday, September 10th. William Blair analyst M. Smock now forecasts that the biopharmSeptember 13, 2024 | marketbeat.comAvid Bioservices to Participate in Craig-Hallum Bioprocessing ConferenceSeptember 12, 2024 | globenewswire.comEquities Analysts Set Expectations for Avid Bioservices, Inc.'s Q1 2026 Earnings (NASDAQ:CDMO)Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) - Equities research analysts at William Blair issued their Q1 2026 earnings estimates for shares of Avid Bioservices in a research note issued on Tuesday, September 10th. William Blair analyst M. Smock forecasts that the biopharmaceutical companySeptember 12, 2024 | marketbeat.comAvid Bioservices Shares Gain Following Higher Revenue, Positive OutlookSeptember 11, 2024 | marketwatch.comRBC Capital Sticks to Its Buy Rating for Avid Bioservices (CDMO)September 11, 2024 | markets.businessinsider.comRice Hall James & Associates LLC Acquires 178,992 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO)Rice Hall James & Associates LLC raised its holdings in Avid Bioservices, Inc. (NASDAQ:CDMO - Free Report) by 45.8% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 570,089 shares of the biopharmaceutical company's stock after buying anSeptember 11, 2024 | marketbeat.comAvid Bioservices, Inc. (NASDAQ:CDMO) Receives Average Rating of "Moderate Buy" from AnalystsShares of Avid Bioservices, Inc. (NASDAQ:CDMO - Get Free Report) have been given a consensus rating of "Moderate Buy" by the five analysts that are covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation and four have given a buy recommenSeptember 10, 2024 | marketbeat.com Get Avid Bioservices News Delivered to You Automatically Sign up to receive the latest news and ratings for CDMO and its competitors with MarketBeat's FREE daily newsletter. Email Address Let’s be blunt (Ad)Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)! Check out the $100 Challenge now CDMO Media Mentions By Week CDMO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CDMO News Sentiment▼1.020.56▲Average Medical News Sentiment CDMO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CDMO Articles This Week▼43▲CDMO Articles Average Week Get Avid Bioservices News Delivered to You Automatically Sign up to receive the latest news and ratings for CDMO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RIGL News GTHX News HCM News ACAD News DYN News ZLAB News AMRX News MOR News JANX News CPRX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CDMO) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avid Bioservices, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avid Bioservices With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
